articleTranscriptionMay 1, 2011BRONZE OA

Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?

Centre National de la Recherche Scientifique · Inserm · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

This review first discusses ways in which we can evaluate transcription inhibition, describe changes in nuclear structure due to transcription inhibition, and report on genes that are paradoxically stimulated by transcription inhibition. Next, it summarizes the characteristics and mechanisms of commonly used inhibitors: α-amanitin is highly selective for RNAP II and RNAP III but its action is slow, actinomycin D is fast but its selectivity is poor, CDK9 inhibitors such as DRB and flavopiridol are fast and reversible but many genes escape transcription inhibition. New compounds, such as triptolide, are fast and selective and able to completely arrest transcription by triggering rapid degradation of RNAP II.

Citation impact

602
total citations
FWCI
53.74
Percentile
100%
References
97
Citations per year

Authors

1

Topics & keywords

Keywords
  • Transcription (linguistics)
  • Cell biology
  • Transcription factor
  • Chemistry
  • Eukaryotic transcription
  • RNA polymerase II
  • Gene
  • Biology
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.